Guaifenesin Tablet, Extended Release
Product Images NDC 76162-031

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 76162-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Topco Associates Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1200 mg Blister Carton (14 (1 x14) Tablets))

Package Label-principal Display Panel (1200 mg Blister Carton (14 (1 x14) Tablets))
The packaging label for TopCare Maximum Strength Mucus ER, containing guaifenesin extended-release tablets 1200 mg. It shows the product name, strength, dosage form (extended-release tablets), and quantity (56 tablets). The label highlights the product's use as an expectorant to relieve chest congestion and thin mucus, with 12-hour effectiveness. The labeler is Topco Associates LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.